ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 529108 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 529108; 2) Community: the network communities that were significantly associated with the response to NSC 529108; 3) Molecule: the relationships between components within communities and NSC 529108; 4) MDR: the compounds that were significantly associated with the NSC 529108.

NSC Compound Enrichment Correlation
NSC 730868 (+)-(2R,3R)-6-{4-[(3-hydroxymethyl)oxiran-2-yl]buta-1,3-diyn yl}-2H-pyran-2-one 0.00628187335688605 0.05017947
NSC 735030 Null 0.00628187335688605 0.25812468
NSC 737231 Null 0.00628187335688605 0.094341205
NSC 740 Methotrexate 0.00628187335688605 0.49957214
NSC 740024 4-(2-Benzylthio-4-chloro-5-methylbenzenesulfonyl)-5,7-dimeth yl-2,4-dihydro-[1,2,4]triazepin-3-ylideneamine 0.00628187335688605 0.013596027
NSC 740476 Null 0.00628187335688605 0.050546944
NSC 746053 Null 0.00628187335688605 0.095590026
NSC 756404 GW843682X 0.00628187335688605 0.51490258
NSC 763059 Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride 0.00628187335688605 0.27093304
NSC 79093 5-Hydroxy-6,7,8,4'-tetramethoxyflavone 0.00628187335688605 0.42855453
Total:189  Current:61    [First] [Prev] [Next] [Last]